Investigating the Role of EN in NTIS Among Fistula Patients
- Conditions
- Gastrointestinal Fistula
- Registration Number
- NCT02038504
- Lead Sponsor
- Jinling Hospital, China
- Brief Summary
The purpose of this study is to investigate whether enteral nutrition are effective in the treatment of nonthyroidal illness syndrome among fistula patients.
- Detailed Description
Nonthyroidal illness syndrome (NTIS) is a common alterations in thyroid function observed in about 70% of hospitalized patients, with or without acute systemic illnesses. Mechanisms in the pathogenesis of NTIS are not yet well understood. Our previous study demonstrated that NTIS occurred frequently with a prevalence of 57.5% in gastrointestinal fistulas patients. In recent study, it has been shown that early enteral nutrition decreases the duration of hospitalization and mortality in the burn population, indicating a potential role of enteral nutrition in NTIS.In addition, the management of fistula patients requires bundle therapy including Nutrition therapy, especially enteral nutrition.The purpose of this study is to investigate whether enteral nutrition are effective in the treatment of nonthyroidal illness syndrome among fistula patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Clinical diagnosis of gastrointestinal fistula
- Clinical diagnosis of nonthyroidal illness syndrome
- Using enteral nutrition for fistula management
- patients who were prescribed drug which may affect thyroid function before or in our study
- patients who were diagnosed as primary thyroid disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thyroid function Changes of thyroid function from baseline at 1 week,2 week, 3 week and 4 week after enrolled. Thyroid function assessment includes level of free triiodothyronine,total triiodothyronine,free thyroxin,total thyroxin,thyroid stimulating hormone,thyroid stimulating hormone index,and standard thyroid stimulating hormone index
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of General Surgery, Jinling Hospital
🇨🇳Nanjing, Jiangsu, China